Teleflex Incorporated (NYSE:TFX) Plans Quarterly Dividend of $0.34

Teleflex Incorporated (NYSE:TFX) declared a quarterly dividend on Monday, May 12th, RTT News reports. Shareholders of record on Tuesday, May 20th will be paid a dividend of 0.34 per share by the medical technology company on Monday, June 16th. This represents a $1.36 dividend on an annualized basis and a yield of 1.09%.

Teleflex has a dividend payout ratio of 9.7% indicating that its dividend is sufficiently covered by earnings. Research analysts expect Teleflex to earn $15.18 per share next year, which means the company should continue to be able to cover its $1.36 annual dividend with an expected future payout ratio of 9.0%.

Teleflex Price Performance

Teleflex stock opened at $125.10 on Monday. Teleflex has a 12 month low of $120.06 and a 12 month high of $249.91. The stock’s 50 day moving average is $133.86 and its 200-day moving average is $165.91. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $5.53 billion, a price-to-earnings ratio of 24.87, a PEG ratio of 1.73 and a beta of 1.17.

Teleflex (NYSE:TFX) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.88 by $0.03. The business had revenue of $700.67 million for the quarter, compared to the consensus estimate of $699.37 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm’s quarterly revenue was down 5.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $3.21 earnings per share. Equities research analysts expect that Teleflex will post 13.98 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms have weighed in on TFX. Piper Sandler restated a “neutral” rating and set a $140.00 target price (down from $255.00) on shares of Teleflex in a research note on Friday, February 28th. Morgan Stanley cut their target price on Teleflex from $191.00 to $173.00 and set an “overweight” rating for the company in a research note on Monday, May 5th. Truist Financial cut their target price on Teleflex from $140.00 to $137.00 and set a “hold” rating for the company in a research note on Monday, May 5th. Citizens Jmp cut Teleflex from an “outperform” rating to a “market perform” rating in a research note on Thursday, February 27th. Finally, StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 28th. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat.com, Teleflex currently has an average rating of “Hold” and a consensus target price of $164.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.